Pershing Square Sohn Cancer Prize supports early-career independent scientists pursuing bold cancer research to address unmet needs and advance cancer understanding, diagnosis, prevention, or treatment.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): October 2027 (Letter of Intent)
Funding Amounts: $750,000 over three years ($250,000 annually, including indirect costs)
Summary: Supports early-career independent scientists pursuing innovative, high-risk, high-reward cancer research addressing important gaps or unmet needs.
Key Information: Applicants must have two to six years of independent laboratory leadership and may apply only twice.
The Pershing Square Sohn Cancer Prize, an initiative of the Pershing Square Sohn Cancer Research Alliance (PSSCRA), supports early-career scientists across the United States. It provides freedom to pursue bold cancer research at a stage when traditional funding may be lacking. The prize supports radically innovative, scientifically sound projects, including basic research and technological applications, with potential to advance cancer understanding, diagnosis, prevention, or treatment.
Projects should pose a clear biological question, demonstrate strong scientific rationale, and explain how they address an important gap or unmet need. This is a single-investigator award, but collaboration within and across institutions is encouraged. Alongside research funding, PSSCRA connects winners with researchers, industry mentors, and investors to accelerate collaboration between science and business.